Daniil Volov

Daniil Volov

orcid

Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2022 in Профилактическая и клиническая медицина
Verified
Journal Article
Closed access
VKV.V. Khominets
V.V. Khominets
LKLidia I. Kalyuzhnaya
Lidia I. Kalyuzhnaya
AGA.S. Grankin
A.S. Grankin
RFR.F. Fedorov
R.F. Fedorov
DVDaniil Volov
Daniil Volov
AKA.V. Komarov
A.V. Komarov
Традиционные методики замещения костных дефектов в свое время продемонстрировали качественно новый подход к проблеме замещения костных дефектов. По мере их применения открылись некоторые отрицательные стороны традиционных методов и сегодня можно сделать вывод, что существующие традиционные методики замещения значимых дефектов костной ткани не в полной мере удовлетворяют клиницистов, поэтому необходим поиск новых перспективных методик, базирующихся на фундаментальных исследованиях процессов репаративного остеогенеза, некоторые из которых пересматриваются в последние годы. За последние годы накоплен достаточный массив фундаментальных открытий в области тканевой инженерии, которые позволяют рассматривать новые способы восстановления дефектов костной ткани для применения их в клинической практике. Анализ эволюции наиболее распространенных методов замещения костной ткани и поиск перспективных тканеинженерных решений. На основании анализа доступных научных публикаций сравнить современные методики замещения костных дефектов и определить наиболее перспективное направление для исследования и применения в клинической практике. Поиск полноценной альтернативы аутогенной костной ткани приводит к необходимости использования «неординарных» биологически активных материалов, обладающих высокой остеоиндуктивностью. Одной из перспективных методик, на наш взгляд, является использование внеклеточного матрикса из провизорных органов, который так же обладает высокой остеогенной активностью, но при этом безопасен в применении и относительно прост в...

3 July 2024 in Biomimetics
Verified
Journal Article
Open access
PDF file
АKАльбина Kondratenko
Альбина Kondratenko
Dmitry TovpekoDmitry Tovpeko
Dmitry Tovpeko
DVDaniil Volov
Daniil Volov
LKLidia I. Kalyuzhnaya
Lidia I. Kalyuzhnaya
VCVladimir E. Chernov
Vladimir E. Chernov
VSVictor I. Sevastianov
Victor I. Sevastianov
The umbilical cord is a material that enhances regeneration and is devoid of age-related changes in the extracellular matrix (ECM). The aim of this work was to develop a biodegradable scaffold from a decellularized human umbilical cord (UC-scaffold) to heal full-thickness wounds. Decellularization was performed with 0.05% sodium dodecyl sulfate solution. The UC-scaffold was studied using morphological analysis methods. The composition of the UC-scaffold was studied using immunoblotting and Fourier transform infrared spectroscopy. The adhesion and proliferation of mesenchymal stromal cells were investigated using the LIVE/DEAD assay. The local reaction was determined by subcutaneous implantation in mice (n = 60). A model of a full-thickness skin wound in mice (n = 64) was used to assess the biological activity of the UC-scaffold. The proposed decellularization method showed its effectiveness in the umbilical cord, as it removed cells and retained a porous structure, type I and type IV collagen, TGF-β3, VEGF, and fibronectin in the ECM. The biodegradation of the UC-scaffold in the presence of collagenase, its stability during incubation in hyaluronidase solution, and its ability to swell by 1617 ± 120% were demonstrated. Subcutaneous scaffold implantation in mice showed gradual resorption of the product in vivo without the formation of a dense connective tissue capsule. Epithelialization of the wound occurred completely in contrast to the controls. All of these data suggest a potential for the use of the UC-scaffold.

6 September 2024 in Bulletin of the Russian Military Medical Academy
Verified
Journal Article
Open access
PDF file
АKАльбина Kondratenko
Альбина Kondratenko
VCVladimir E. Chernov
Vladimir E. Chernov
Dmitry TovpekoDmitry Tovpeko
Dmitry Tovpeko
DVDaniil Volov
Daniil Volov
NBNikolay V. Beliy
Nikolay V. Beliy
КИКалюжная Лидия Ивановна
Калюжная Лидия Ивановна
The bacteriostatic effects of human umbilical cord-derived matrices and hydrogels were examined. The use of biomimetics based on the extracellular matrix of extraembryonic organs, including the human umbilical cord, is promising for regenerative medicine and tissue engineering. Cell-free products from the extracellular matrix of various human organs and tissues are resistant to intentional bacterial contamination. Two acellular scaffolds prepared using different human umbilical cord decellularization protocols and two derived hydrogels were evaluated for their bacteriostatic properties. Two clinical cases of the use of lyophilisates of umbilical cord-derived hydrogels were described. The compositions of human umbilical cord-derived acellular matrices and hydrogels were studied using biochemical analysis techniques. The sensitivities of Staphylococcus aureus and Escherichia coli to umbilical cord-derived matrices and hydrogels were assessed using culture techniques, and metabolic activities of bacteria were also examined. Human umbilical cord-derived acellular matrices and hydrogels consist of collagens and contain proteins and glycosaminoglycans. A significant bacteriostatic effect of hydrogels against Escherichia coli was detected during the first 16 h of incubation, regardless of the type of detergents used for their preparation. The matrices did not show a bacteriostatic effect, which indicates that the hydrolysis of structural components contributes to the release of substances with bacteriostatic activities. The effect was presumed to be due to the influence on the level of metabolic activity of microorganisms. The use of powdered lyophilized hydrogels derived from human umbilical cord as an adjunct to autodermal graft in the treatment of infected deep wounds in two volunteer patients promoted healing without infections. In general, the use of hydrogel lyophilisates from acellular human umbilical cord as an additional treatment allows for the engraftment of skin autografts and promotes the healing of extensive deep wounds at risk of infection.

20 August 2026 in Bulletin of the Russian Military Medical Academy
Verified
Journal Article
Closed access
PDF file
VKVladimir V. Khominets
Vladimir V. Khominets
ХВХоминец Владимир Васильевич
Хоминец Владимир Васильевич
DVDaniil Volov
Daniil Volov
ВАВолов Даниил Александрович
Волов Даниил Александрович
MTMaxim V. Tkachenko
Maxim V. Tkachenko
БВБолгов Илья Владиславович
Болгов Илья Владиславович
BACKGROUND: The treatment of large post-traumatic tissue defects in the extremities is an urgent problem at the intersection of regenerative medicine, traumatology and orthopedics, and plastic and reconstructive surgery due to the increasing frequency of such injuries, prolonged treatment, and high complication rates. AIM: To develop a method for filling a large soft tissue and bone defect in the shoulder girdle after a gunshot wound to the upper limb, and to demonstrate the potential of a new method for shoulder joint arthrodesis using autotransplantation and a patient-specific implant made using additive manufacturing (3D printing). METHODS: A visual analog scale, a brief upper limb disability questionnaire, the Constant–Murley scale, and a specialized scale for assessing shoulder joint condition were used for subjective assessment of treatment outcomes. RESULTS: After the surgical procedures, all patients (n = 35) had a maximum bone graft length of 16.5 cm, a minimum length of 7 cm, a minimum limb shortening of 0 cm, and a maximum limb shortening of 5.5 cm. After 3 and 6 months, all patients underwent multidetector computed tomography (MDCT) and scintigraphy to monitor the process of bone graft remodeling and the formation of glenohumeral arthrodesis. 18 months after shoulder arthrodesis, the intensity of pain on a visual analogue scale decreased from 8 to 1 point (p 0.001). Indicators of functional deficit on a brief questionnaire of inability of the upper limb decreased from 85 to 23 points (p 0.001). A significant improvement was also recorded on the Constant–Murley score, from 8 to 43 points, and on the specialized scale for assessing the condition of the shoulder joint, from 15 to 62 points (p 0.001), which reflects a significant improvement in the support and strength function of the limb in the absence of active movements in the shoulder joint. CONCLUSION: Glenohumeral arthrodesis for severe gunshot wounds, implemented as part of a developed protocol, namely: debridement of the lesion site and soft tissue defect reconstruction, planning of bone reconstruction, patient-specific digital modeling, and virtual planning of surgery using patient-specific 3D-printed titanium systems, has shown that controlled interfragmentary compression and reliable integration of the bone graft can achieve high stability and good upper limb function even in extremely complex cases.

7 March 2026 in Problems of Endocrinology
Verified
Journal Article
Open access
PDF file
SCSergeY Chebotarev
SergeY Chebotarev
Dmitry TovpekoDmitry Tovpeko
Dmitry Tovpeko
LKLidia I. Kalyuzhnaya
Lidia I. Kalyuzhnaya
MKM. E. Kotova
M. E. Kotova
АKАльбина Kondratenko
Альбина Kondratenko
VSV. V. Salukhov
V. V. Salukhov
Non-healing ulcers pose a serious problem for public health due to the high cost of treatment, prolonged disability of patients, and low efficacy of therapy. They are the leading cause of non-traumatic lower limb amputations. The development of innovative bioengineering products is a significant step in the treatment of non-healing diabetic foot ulcers. One such product is a tissue-engineered acellular product made from highly regenerative human umbilical cord biomaterial. It contains growth factors, cytokines, and components of the extracellular matrix of Wharton’s jelly, which accelerates wound healing. THE AIM of this clinical study is to evaluate the safety and efficacy of a tissue-engineered acellular product from Wharton’s jelly of the umbilical cord for the treatment of chronic non-healing lower limb ulcers in patients with diabetic foot syndrome. RESULTS: a 60-year-old woman diagnosed with type 2 diabetes mellitus had chronic ulcers that had not responded to standard treatment for more than a year and a half. She was observed for 4 weeks in August 2024. As a result of the local application of an acellular product from human umbilical cord, signs of reduction in wound size and their complete healing were noted 4 weeks after the start of observation. CONCLUSION: clinical observation has demonstrated the safety and efficacy of the acellular product from human umbilical cord for the treatment of chronic non-healing ulcers of diabetic origin.